Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2018-07
  • Cell Counting Kit-8 (CCK-8): High-Sensitivity WST-8 Cell ...

    2025-12-02

    Cell Counting Kit-8 (CCK-8): High-Sensitivity WST-8 Cell Viability Assay

    Executive Summary: The Cell Counting Kit-8 (CCK-8) utilizes a water-soluble tetrazolium salt, WST-8, which is bioreduced by mitochondrial dehydrogenases in viable cells to yield a quantitative, colorimetric readout correlating with cell number (APExBIO; Song et al., 2024). The CCK-8 assay is more sensitive and less toxic than MTT, XTT, and WST-1 tests, allowing direct measurement without solubilization steps (Reference). It is extensively used in oncology, neurodegenerative disease, and cytotoxicity studies for high-throughput or routine cell viability assessments. APExBIO's CCK-8 (K1018) offers reproducible results and streamlined protocols, supporting translational, toxicological, and metabolic research (Reference). The assay has defined boundaries, as it is not suitable for non-metabolically active cells, and may be influenced by compounds interfering with mitochondrial function.

    Biological Rationale

    Quantitative measurement of cell viability is fundamental in biomedical research. Assessments of cell proliferation, cytotoxicity, and metabolic activity underpin studies in cancer, neurodegeneration, toxicology, and pharmacology (Song et al., 2024). Traditional assays like MTT and XTT require additional solubilization steps, are less sensitive, and may be cytotoxic (Ref). The Cell Counting Kit-8 (CCK-8), based on the water-soluble tetrazolium salt WST-8, enables direct, non-radioactive, and highly sensitive detection of viable cells by coupling cellular metabolic activity to a colorimetric readout. This approach is especially valuable for high-throughput screening and studies requiring minimal cell perturbation.

    Mechanism of Action of Cell Counting Kit-8 (CCK-8)

    CCK-8 contains WST-8, a water-soluble tetrazolium salt. In viable cells, intracellular dehydrogenases, primarily mitochondrial, reduce WST-8 to form a water-soluble formazan dye with an orange color (APExBIO). The reaction is strictly dependent on NADH/NADPH produced during cellular metabolism. The amount of formazan generated is directly proportional to the number of metabolically active cells. The formazan product's absorbance is measured at 450 nm using a microplate reader. Unlike MTT, the CCK-8 assay does not require organic solvents or cell lysis for solubilization, reducing assay time and cell stress (Ref). This mechanism ensures high sensitivity and reproducibility, with minimal interference from serum or phenol red in the medium.

    Evidence & Benchmarks

    • WST-8 reduction by viable cells yields a linear correlation between absorbance at 450 nm and cell number in the range of 5×102–1×105 cells per well (APExBIO).
    • CCK-8 demonstrates higher sensitivity and lower cytotoxicity than MTT, XTT, and WST-1 in parallel cell viability and cytotoxicity assays (Reference).
    • In neurotoxicity studies, CCK-8 reliably quantifies apoptosis and mitochondrial dysfunction in N2A cells after exposure to triclocarban at concentrations as low as 1 μM for 24 hours (Song et al., 2024).
    • CCK-8 is validated for use in various cell lines (e.g., cancer, neuronal, stem cells) and primary cells, providing reproducible results across different buffer systems (pH 7.2–7.4, 37°C incubation, 1–4 hours) (Reference).
    • Direct measurement of mitochondrial dehydrogenase activity by CCK-8 enables assessment of metabolic changes linked to disease, drug exposure, or gene editing (Song et al., 2024).

    Applications, Limits & Misconceptions

    CCK-8 is widely applied in:

    • Cancer research: Quantifying cell proliferation and cytotoxic effects of chemotherapeutics (Song et al., 2024).
    • Neurodegenerative disease studies: Measuring neuronal viability and apoptosis in response to neurotoxins or gene silencing (Reference).
    • Toxicology: Screening environmental chemicals (e.g., triclocarban) for mitochondrial dysfunction or cell death in vitro (Song et al., 2024).
    • Pharmacology: Evaluating drug efficacy and cytotoxicity in primary or immortalized cell lines (Reference).

    This article extends the analysis in this review of WST-8-based viability assays by providing updated, peer-reviewed application evidence in neurotoxicology and benchmarking CCK-8 against recent regulatory standards. Whereas this prior article focuses on translational and regenerative contexts, here we clarify the kit's workflow integration and address common misconceptions.

    Common Pitfalls or Misconceptions

    • CCK-8 is not suitable for quantifying non-metabolically active or dead cells, as WST-8 reduction requires active mitochondrial enzymes.
    • Compounds that alter mitochondrial membrane potential or directly reduce tetrazolium salts (e.g., ascorbic acid, certain antioxidants) may interfere with assay readouts (Song et al., 2024).
    • High concentrations of serum proteins or reducing agents in culture media may cause background signal or false positives.
    • Assay sensitivity may be limited at very low cell densities (<500 cells/well) or in non-adherent cell types unless protocol is optimized.
    • The assay does not distinguish between cell proliferation and increased metabolic rate per cell; parallel controls are needed for interpretation.

    Workflow Integration & Parameters

    The Cell Counting Kit-8 (CCK-8) (SKU: K1018) from APExBIO is designed for high-throughput and routine cell viability measurements. Standard workflow:

    1. Seed cells in 96-well or 384-well plates at 5×102–1×105 cells per well in 100 μL culture medium.
    2. Incubate cells with test compounds or controls under standard conditions (37°C, 5% CO2).
    3. Add 10 μL of CCK-8 reagent directly to each well. No cell washing or medium replacement is required.
    4. Incubate for 1–4 hours, depending on cell type and density. Color development is stable for at least 2 hours post-incubation.
    5. Measure absorbance at 450 nm using a microplate reader. Subtract blank values (media + CCK-8, no cells) for background correction.

    Parameters such as incubation time and cell density should be empirically optimized for each cell line. The kit is compatible with most serum-containing and serum-free media. For best results, avoid using strong reducing agents or colored compounds that absorb at 450 nm.

    Conclusion & Outlook

    Cell Counting Kit-8 (CCK-8) provides a rapid, sensitive, and reproducible method for quantifying cell viability, proliferation, and cytotoxicity. Its WST-8 chemistry offers distinct advantages over legacy assays, including water solubility, non-toxic workflow, and direct readout. CCK-8 is suitable for diverse applications in cancer, neurodegeneration, and toxicology. As demonstrated in recent multi-omics studies, CCK-8 is an indispensable tool for linking mitochondrial function with cellular health (Song et al., 2024). Continued integration of CCK-8 into automated and multiplexed platforms will further advance cell-based research. For detailed protocols and product support, refer to APExBIO's CCK-8 product page.